CGM is a legal “reasonable accommodation” Why are many schools still fighting it?

This week, legal rights and diabetes have come a long way – but as the technology changes, so have some of the challenges. What happens when a school refuses to use CGM technology? I’m talking to two attorneys this week who have actionable advice and the law on their side. The Dept of Justice has already ruled on this in one state, in a decision that has nationwide impact. Bonnie Roswig is an attorney with the small non profit Center for Children’s Advocacy which focuses on addressing legal needs of vulnerable children. Jonathan Chappell lives with type 1 and is a private practice lawyer in Connecticut. They recently filed an administrative complaint with DOJ in the Eastern district of VA, with more to come. They've also created a template for families, on their own to download, complete, and file on their own: Here's more information for parents There's also a Facebook group that is following this issue: https://www.facebook.com/groups/followt1ds This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Don't miss our Diabetes Summer Camp Webinar this week! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: [email protected]

There are no comments yet.

Please log in to write the first comment.